Introduction to “Immunotherapies for Multiple Myeloma”
Note: In lieu of an abstract, this is an excerpt from the first page.
Multiple myeloma (MM) is the second most common hematological cancer after diffuse large B-cell lymphoma, accounting for about 10% of all blood cancers […]
View Full-Text
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
Published at Tue, 17 Nov 2020 03:05:54 +0000